Opinion: Biotech is back. Here’s why these rallying stocks belong in your portfolio now.

Published: Nov. 3, 2025 at 9:58 a.m. ET Biotech stocks are emerging from a four-year slump. The…

Amazon’s new OpenAI deal offers further proof the stock has become an AI winner

Last week Amazon CEO Andy Jassy hinted at more big deals. The $38 billion OpenAI partnership…

Opinion: How to know if a CEO shakeup is a ‘buy’ signal for a stock

Outside the Box Be skeptical if the selection seems status quo when the company needs a…

Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion

Published: Nov. 3, 2025 at 8:27 a.m. ET Consumer goods giant Kimberly-Clark Corp. announced Monday a deal…

Sam Altman was finally asked the big question on OpenAI and its spending spree

OpenAI’s Sam Altman sat down with Microsoft chief Satya Nadella for what he must’ve imagined would…